Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned:
Quaker BioVentures II, L.P. – 2,189,994
Quaker BioVentures Capital II, L.P. – 2,189,994
Quaker BioVentures Capital II, LLC – 2,195,463
(b)
Percent of class:
Quaker BioVentures II, L.P. – 8.82%
Quaker BioVentures Capital II, L.P. – 8.82%
Quaker BioVentures Capital II, LLC – 8.84%
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote
Quaker BioVentures II, L.P. – 0
Quaker BioVentures Capital II, L.P. – 0
Quaker BioVentures Capital II, LLC – 5,469
(ii) Shared power to vote or to direct the vote
Quaker BioVentures II, L.P. – 2,189,994
Quaker BioVentures Capital II, L.P. – 2,189,994
Quaker BioVentures Capital II, LLC – 2,189,994
(iii) Sole power to dispose or to direct the disposition of
Quaker BioVentures II, L.P. – 0
Quaker BioVentures Capital II, L.P. – 0
Quaker BioVentures Capital II, LLC – 5,469
(iv) Shared power to dispose or to direct the disposition of
Quaker BioVentures II, L.P. – 2,189,994
Quaker BioVentures Capital II, L.P. – 2,189,994
Quaker BioVentures Capital II, LLC – 2,189,994
Quaker BioVentures Capital II, L.P. (“Quaker Capital L.P.”) is the general partner of Quaker BioVentures II, L.P., and Quaker BioVentures Capital II, LLC (“Quaker Capital LLC”) is the general partner of Quaker Capital L.P. Richard S. Kollender, who is a director of the Issuer and a managing members of Quaker BioVentures, holds 5,469 shares of common stock of the Issuer. Quaker Capital LLC may be deemed to beneficially own the shares held by Mr. Kollender. Mr. Kollender does not have or share voting or dispositive power over the Shares.
|